Noninvasive Prenatal Screening (NIPS) (NIPT)
Test Description:
Noninvasive prenatal screening (NIPS*) using cell-free DNA testing is currently the most sensitive and specific screening test for common fetal aneuploidies involving chromosomes 21, 18, 13, X, and Y with optional fetal sex detection. This test can be completed as early as 10 weeks gestational age. NIPS can provide expecting mothers the knowledge needed to make medical decisions regarding pregnancy, including the decision to pursue more invasive testing methods. NIPS is the best option for expecting patients to predict the likelihood of certain chromosome aneuploidies such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13), and sex chromosome aneuploidies. NIPS is now endorsed by the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine for all patients, regardless of maternal age. This test is suitable for singleton and twin pregnancies and IVF with egg donor pregnancies (singleton and twin).Methodology: Next Generation Sequencing of Cell-Free DNA
*Sometimes referred to as Noninvasive prenatal testing (NIPT)Billing
81420
Ordering
Test Code
NGS Cell Free DNA
Additional Test Codes
NIPS
NIPT
Turnaround Time
4 - 6 Days
Non-Prenatal Specimens
- Minimum Volume: 7-10 mL whole blood
- Container: Streck Cell-Free BCT, collect two tubes
- Collection: Specimen must be collected at or after 10 weeks gestation
Shipping
Ship all specimen types at room temperature by overnight courier. Do not freeze. For more details and to download the required forms, please visit our shipping page.